ABBV vs. AXON
ABBV (AbbVie Inc.) and AXON (Axon Enterprise, Inc.) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while AXON operates in Aerospace & Defense (Industrials). Over the past 10 years, ABBV returned 19.10%/yr vs 34.58%/yr for AXON. At a 0.15 correlation, their price movements are largely independent.
Performance
ABBV vs. AXON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a 1.30% return, which is significantly higher than AXON's -22.22% return. Over the past 10 years, ABBV has underperformed AXON with an annualized return of 19.10%, while AXON has yielded a comparatively higher 34.58% annualized return.
ABBV
- 1D
- 1.32%
- 1M
- 8.24%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
AXON
- 1D
- -1.00%
- 1M
- 12.72%
- YTD
- -22.22%
- 6M
- -21.72%
- 1Y
- -43.41%
- 3Y*
- 30.96%
- 5Y*
- 22.92%
- 10Y*
- 34.58%
ABBV vs. AXON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
AXON Axon Enterprise, Inc. | -22.22% | -4.44% | 130.06% | 55.69% | 5.69% | 28.13% | 67.21% | 67.50% | 65.09% | 9.32% |
Correlation
The correlation between ABBV and AXON is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.15 |
The correlation between ABBV and AXON shifts across timeframes, from -0.09 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ABBV:
$403.99B
AXON:
$36.43B
ABBV:
$2.05
AXON:
$2.41
ABBV:
110.96
AXON:
183.64
ABBV:
6.43
AXON:
12.70
ABBV:
14.69
AXON:
10.31
ABBV:
$62.82B
AXON:
$2.98B
ABBV:
$46.15B
AXON:
$1.77B
ABBV:
$17.96B
AXON:
$156.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. AXON — Risk / Return Rank
ABBV
AXON
ABBV vs. AXON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Axon Enterprise, Inc. (AXON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABBV | AXON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.69 | ||
| Sortino ratioReturn per unit of downside risk | +2.46 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 0.87 | +0.31 |
| Calmar ratioReturn relative to maximum drawdown | 1.29 | -0.72 | +2.00 |
| Martin ratioReturn relative to average drawdown | 2.88 | -1.22 | +4.10 |
Loading charts...
Drawdowns
ABBV vs. AXON - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum AXON drawdown of -91.78%. Use the drawdown chart below to compare losses from any high point for ABBV and AXON.
Loading charts...
Drawdown Indicators
| ABBV | AXON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -91.78% | +46.69% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -60.28% | +42.96% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -60.28% | +39.54% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -60.28% | +38.36% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -60.28% | +15.19% |
Current DrawdownCurrent decline from peak | -4.60% | -49.28% | +44.68% |
Average DrawdownAverage peak-to-trough decline | -10.71% | -43.60% | +32.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.75% | 35.34% | -27.59% |
Volatility
ABBV vs. AXON - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 6.10%, while Axon Enterprise, Inc. (AXON) has a volatility of 17.73%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than AXON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | AXON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 17.73% | -11.63% |
Volatility (6M)Calculated over the trailing 6-month period | 17.85% | 44.20% | -26.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.31% | 55.66% | -31.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 47.94% | -25.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.73% | 49.18% | -23.45% |
Dividends
ABBV vs. AXON - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.96%, while AXON has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
AXON Axon Enterprise, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ABBV vs. AXON - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Axon Enterprise, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. AXON - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
AXON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axon Enterprise, Inc. reported a gross profit of 477.29M and revenue of 807.35M. Therefore, the gross margin over that period was 59.1%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
AXON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axon Enterprise, Inc. reported an operating income of 29.24M and revenue of 807.35M, resulting in an operating margin of 3.6%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
AXON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axon Enterprise, Inc. reported a net income of 169.31M and revenue of 807.35M, resulting in a net margin of 21.0%.
Frequently Asked Questions
ABBV and AXON have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXON has higher volatility (17.73%) compared to ABBV (6.10%). In terms of maximum drawdown, ABBV dropped -45.09% vs AXON's -91.78%.
ABBV currently has the higher Sharpe Ratio (0.92 vs -0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and AXON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer